ArticleCancer discovery2015

EGFR Kinase Domain Duplication (EGFR-KDD) Is a Novel Oncogenic Driver in Lung Cancer That Is Clinically Responsive to Afatinib.

Jean-Nicolas Gallant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.